他汀类药物与卒中

被引:1
作者
乔曼丽
机构
[1] 民航总医院神经内科
关键词
他汀类药物; 卒中; 血脂;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
他汀类药物能够明显降低卒中的发病风险,其作用机制除调节血脂之外,更重要的是多重血管保护作用。在严格掌握剂量、适应证、禁忌证,并且在必要时定期随访和监测的情况下,他汀类药物的长期应用是安全的。他汀类药物的应用在我国还处于较低水平,应当在更大范围的人群中发挥其卒中保护作用。
引用
收藏
页码:164 / 167
页数:4
相关论文
共 11 条
  • [1] Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study)
    Serebruany, Victor L.
    Miller, Michael
    Pokov, Alex N.
    Malinin, Alex I.
    Lowry, David R.
    Tanguay, Jean-Francois
    Hennekens, Charles H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (09) : 1332 - 1336
  • [2] Comparative Safety of Atorvastatin 80 mg Versus 10 mg Derived from Analysis of 49 Completed Trials in 14,236 Patients[J] . Connie Newman,John Tsai,Michael Szarek,Don Luo,Eric Gibson.The American Journal of Cardiology . 2006 (1)
  • [3] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins[J] . The Lancet . 2005 (9493)
  • [4] Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis[J] . Pierre Amarenco,Julien Labreuche,Philippa Lavallée,Pierre-Jean Touboul.Stroke . 2004 (12)
  • [5] Effects of Statins on Endothelium and Signaling Mechanisms[J] . Matthias Endres,Ulrich Laufs.Stroke . 2004 (11 S)
  • [6] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial[J] . Helen M Colhoun,D John Betteridge,Paul N Durrington,Graham A Hitman,H Andrew W Neil,Shona J Livingstone,Margaret J Thomason,Michael I Mackness,Valentine Charlton-Menys,John H Fuller.The Lancet . 2004 (9435)
  • [7] Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
    Chalasani, N
    Aljadhey, H
    Kesterson, J
    Murray, MD
    Hall, SD
    [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1287 - 1292
  • [8] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] . The Lancet . 2003 (9364)
  • [9] Withdrawal of statin treatment abrogates stroke protection in mice
    Gertz, K
    Laufs, U
    Lindauer, U
    Nickenig, G
    Böhm, M
    Dirnagl, U
    Endres, M
    [J]. STROKE, 2003, 34 (02) : 551 - 557
  • [10] Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation[J] . Anetta Undas,Kathleen E. Brummel,Jacek Musial,Kenneth G. Mann,Andrew Szczeklik.Circulation: Journal of the American Heart Association . 2001 (18)